Robert Konschak
Overview
Explore the profile of Robert Konschak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lodrini M, Sprussel A, Astrahantseff K, Tiburtius D, Konschak R, Lode H, et al.
Oncotarget
. 2017 Nov;
8(49):85234-85251.
PMID: 29156716
The invasive nature of surgical biopsies deters sequential application, and single biopsies often fail to reflect tumor dynamics, intratumor heterogeneity and drug sensitivities likely to change during tumor evolution and...
2.
Niehr F, Eder T, Pilz T, Konschak R, Treue D, Klauschen F, et al.
Clin Cancer Res
. 2017 Oct;
24(1):158-168.
PMID: 29061642
Platinum-based drugs, in particular cisplatin (cis-diamminedichloridoplatinum(II), CDDP), are used for treatment of squamous cell carcinoma of the head and neck (SCCHN). Despite initial responses, CDDP treatment often results in chemoresistance,...
3.
Braunholz D, Saki M, Niehr F, Ozturk M, Borras Puertolas B, Konschak R, et al.
PLoS One
. 2016 Sep;
11(9):e0163149.
PMID: 27643613
In solid tumours millions of cells are shed into the blood circulation each day. Only a subset of these circulating tumour cells (CTCs) survive, many of them presumable because of...
4.
Tinhofer I, Niehr F, Konschak R, Liebs S, Munz M, Stenzinger A, et al.
Radiat Oncol
. 2015 Aug;
10:183.
PMID: 26316159
The introduction of next-generation sequencing (NGS) in the field of cancer research has boosted worldwide efforts of genome-wide personalized oncology aiming at identifying predictive biomarkers and novel actionable targets. Despite...
5.
Hristozova T, Konschak R, Budach V, Tinhofer I
Cytometry A
. 2012 Mar;
81(6):489-95.
PMID: 22438318
Circulating tumor cells (CTCs) might not only serve as prognostic marker but could also be useful for monitoring treatment efficacy. A multicolor flow cytometry protocol for their detection and molecular...
6.
Konschak R, Tinhofer I
Clin Chem Lab Med
. 2011 Mar;
49(6):1069-71.
PMID: 21410414
No abstract available.
7.
Sinn B, Schulze J, Schroeder G, Konschak R, Freyer D, Budach V, et al.
Radiat Res
. 2010 Aug;
174(5):601-10.
PMID: 20718603
Activation of p53 has been causally linked to normal tissue damage after irradiation. Pifithrin-α (PFT-α), a specific inhibitor of p53, has been suggested as a combinatory agent in the treatment...